Australia multiplex testing reagents type outlook (Revenue, USD million, 2021-2033)
- Biotin-based Reagents
- Biotinylated Antibodies
- Biotinylated Probes/primers
- Biotin-tagged Proteins/enzymes
- Streptavidin-based Reagents
- Streptavidin-conjugated Beads/microspheres
- Streptavidin-conjugated Enzymes & Fluorophores
- Recombinant Streptavidin Variants (engineered for higher stability)
- Others
Australia multiplex testing reagents application outlook (Revenue, USD million, 2021-2033)
- Autoimmune Disease Diagnostics
- Infectious Disease Diagnostics
- Oncology
- Allergy Testing
- Research & Translational Medicine
- Drug Discovery & Development
- Others
Australia multiplex testing reagents end use outlook (Revenue, USD million, 2021-2033)
- Clinical & Diagnostic Laboratories
- Hospitals
- Pharmaceutical & BioApplication Companies
- Contract Research Organizations (CROs)
- Academic & Research Institutes
